Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
Ruzicka T, Hanifin JM, Furue M, Pulka G, Mlynarczyk I, Wollenberg A, Galus R, Etoh T, Mihara R, Yoshida H, Stewart J, Kabashima K; XCIMA Study Group. Ruzicka T, et al. Among authors: hanifin jm. N Engl J Med. 2017 Mar 2;376(9):826-835. doi: 10.1056/NEJMoa1606490. N Engl J Med. 2017. PMID: 28249150 Free article. Clinical Trial.
The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study.
Nemoto O, Furue M, Nakagawa H, Shiramoto M, Hanada R, Matsuki S, Imayama S, Kato M, Hasebe I, Taira K, Yamamoto M, Mihara R, Kabashima K, Ruzicka T, Hanifin J, Kumagai Y. Nemoto O, et al. Br J Dermatol. 2016 Feb;174(2):296-304. doi: 10.1111/bjd.14207. Epub 2015 Dec 19. Br J Dermatol. 2016. PMID: 26409172 Clinical Trial.
Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review.
Barbarot S, Rogers NK, Abuabara K, Aubert H, Chalmers J, Flohr C, Hanifin J, Naldi L, Margolis DJ, Paul C, Ridd MJ, Schuttelaar MA, Simpson E, Tauber M, Volke A, Weidinger S, Wilkes SR, Wollenberg A, Thomas KS. Barbarot S, et al. J Am Acad Dermatol. 2016 Nov;75(5):1038-1044. doi: 10.1016/j.jaad.2016.05.043. Epub 2016 Aug 10. J Am Acad Dermatol. 2016. PMID: 27522613 Review.
New and developing therapies for atopic dermatitis.
Hajar T, Gontijo JRV, Hanifin JM. Hajar T, et al. Among authors: hanifin jm. An Bras Dermatol. 2018 Jan-Feb;93(1):104-107. doi: 10.1590/abd1806-4841.20187682. An Bras Dermatol. 2018. PMID: 29641707 Free PMC article.
An overview of atopic dermatitis.
Hanifin JM. Hanifin JM. Dermatol Nurs. 2003 Aug;Suppl:6-9. Dermatol Nurs. 2003. PMID: 14520891 Review.
Efalizumab for severe atopic dermatitis: a pilot study in adults.
Takiguchi R, Tofte S, Simpson B, Harper E, Blauvelt A, Hanifin J, Simpson E. Takiguchi R, et al. J Am Acad Dermatol. 2007 Feb;56(2):222-7. doi: 10.1016/j.jaad.2006.08.031. Epub 2006 Oct 13. J Am Acad Dermatol. 2007. PMID: 17097386
The role of antihistamines in atopic dermatitis.
Hanifin JM. Hanifin JM. J Allergy Clin Immunol. 1990 Oct;86(4 Pt 2):666-9. doi: 10.1016/s0091-6749(05)80237-4. J Allergy Clin Immunol. 1990. PMID: 1699988 Review.
Atopic dermatitis.
Simpson EL, Hanifin JM. Simpson EL, et al. Among authors: hanifin jm. J Am Acad Dermatol. 2005 Jul;53(1):115-28. doi: 10.1016/j.jaad.2005.01.130. J Am Acad Dermatol. 2005. PMID: 15965431 No abstract available.
292 results